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Introduction 
 Environmental occurrence of organic pollutants through 
interconnectedness of human actions and activities impacts the 
environment in many ways. The impacts arising from the 
potential of global warming, deforestation and deposition of 
drugs comprising myriads of chemical and therapeutic classes 
harbours risks to our daily lives.  The high consumption of drugs 
have significant worldwide consequences and the 
comprehensive assessment to provide updates regarding the 
occurrence, metabolism, measurement as well as removal of 
these contaminants from STWs effluent-waters have therefore 
become important for humans and aquatic environment.  
Occurrence of chemical substances in the aquatic 
environment  
Heavy metals, solvents, dyes, pesticides etc. are some of the 
chemicals that enter the aquatic environment in several ways 
causing chemical pollution. Some are either from sewage 
treatment works (STWs) or are dumped directly from industrial 
effluents. Other sources include the use of herbicides and 
fertilizers in agriculture. Apart from phytoestrogens that come 
from plants; humans and animals also excrete natural hormones 
which are disrupting chemicals in the environment [1]. In 
effluents, bisphenol A (BPA), nonylphenol, nitrates found in 
fertilizers as well as animal excrements and industrial chemicals 
occur [2]. Figure 1, shows also the presence of polycyclic-
aromatic hydro carbons (PAHs), heavy metals and phthalates are 
shown. 
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Figure 1:  Chemical components in sewage sludge. Data 
from The U. S. Environmental Protection Agency. 
(Renewable Energy Venture, Austin, Texas) [4] 
Other classes of endocrine disrupting compounds (EDCs), 
which includes multitudes of chemicals are considered in the 
studies of accumulation of potential toxic elements exposed to 
sheep grazed on grassland with repeated applications of sewage 
sludge and its exposure effects on sheep foetal testis 
development at different gestation periods [3, 4] have been 
reported. The chemicals used in the plastic industry includes 
phthalate esters and other major environmental pollutants [5] 
and Koppe et al [6] studied the metabolism of the parent 
phthalate and argued that a very active glucuronidated 
metabolite (monoester) was excreted, while in the digestive 
system their higher monomers has been detected [7].  
Table 1 shows most of the reported data of pollutants and 
residual analytes in sewage samples showing the sources and the 
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The individual use of these pharmacologically active substances which generate great but 
underappreciated levels of other toxicologically potent and associated bioactive metabolites 
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determination. The application of this method to the actual influents, effluents, sludge and 
environmental sediments from sewage treatment works (STWs) allows the assessment of 
drugs content and  the extent at which STW helps in the transport of these pollutants (via 
different media) into the environment. The capability is also outlined for furthering our 
understanding of fate and behaviour of drugs with particular reference to illicit drugs, abused 
pharmaceuticals and environmental processes in our quest to understand the overall issues of 
drugs and make available exposure data for the aquatic realm. 
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analytes found. In foetus studies, high bioaccumulation of 
phthalates due to easy placental transfer [8] has been observed 
and the effects of high doses of phthalates on male’s 
reproductive organs have been shown but in most organ 
systems, they are relatively non-toxic. A reduction in 
testosterone production in rats exposed to phthalates confirmed 
extensive studies of phthalates with the increased high levels of 
human exposure in human spermatozoa increased damage to 
DNA [9-14].  
Activity effects of dibutyl phthalate (DBP) [62], di-
ethylhexyl phthalate (DEHP) induced ‘anti-androgenic’ on 
humans testicular dysgenesis syndrome [63], multinucleate 
gonocytes in rats [64-66] and occurrence of oestrogens on breast 
cancer cells have been linked to phthalate exposures [67].  
Polychlorinated biphenyls (PCBs) are (unreactive) organic 
compounds, which constitute a class of 209 congener groups. 
The commercial production of pulp bleaching, herbicides, metal 
smelting, by-products in combustion processes of incineration, 
chlor-alkali and coal-fired power stations or processes are main 
sources of PCBs stable compounds. Rudel et al [68] had listed 
their uses as electronic components, pesticides extenders, cutting 
oils, sealants, adhesives, stabilizing additives in flexible PVC 
coatings of electrical wiring, wood floor production, finishers, 
flame retardants, hydraulic fluids, paints, de-dusting agents 
coolants, insulating fluids for transformers, capacitors, and in 
carbonless copy paper.  PCBs are stable, very resistant to 
oxidative degradation, only degrade anaerobically and readily 
persist longer [69]. On human health effects, anemia, thyroid 
gland injuries, impaired reproduction, stomach and liver injuries 
have all been reported [70, 71].  Exposures of PCBs can 
interfere with oestrogen levels of animals [72].  Impairments of 
immune system, lowering of testosterone levels in males, 
elevating the levels of progesterone in females and disruption of 
thyroid hormone function [73].  Bioaccumulation of PCBs 
induces oestrogenic effects in animal tissues [74]. Additional 
studies from Whyatt et al [75], Lilienthal [76] and Korach [77] 
have all further confirmed that the chlorinated congeners are 
more stable and persistent longer than less chlorinated 
compounds. 
Pharmaceuticals in aqueous environment 
Pharmaceutical substances are pollutants that are steadily 
increasing in wide variety in the aquatic environment apart from 
the traditional pollutants like polychlorinated biphenyls (PCBs), 
pesticides and polycyclic aromatic hydrocarbons (PAHs) in 
recent years [78-83]. Despite the rapid rise and continuous 
discharge of these chemicals of which some are carcinogenic, 
reproductive toxic and mutagenic in environmental matrices 
[84-87], studies have indicated that their removals have been 
found to be incomplete and inadequate attention on the fate and 
behaviour during the transport of many drugs after their 
intended use have increased the risks of possible environmental 
effects [88-92]. The active ingredients of medicinal products 
with a wide range of chemical structures are excreted as parent 
drugs with associated metabolites after metabolism by dosed 
user and these are further subjected to biotransformation in the 
sewage treatment processes producing more polar degradation 
products of which many complex modes of biochemical 
pathways are poorly understood. This has led environmental 
research’s increasing attention to pharmaceuticals and their 
corresponding metabolites considering the production of large 
number of registered pharmaceuticals and those procured 
illegally for illicit use or without prescription [89]. Yet, large 
quantities of different chemical classes of new pharmaceuticals 
enter the already saturated marketplace and these are disposed 
through agrochemicals runoff and the sewage systems to the 
aquatic environment 
One of the major sources is excreta and urine containing the 
unmetabolized drug residues and its active metabolites being 
flushed down in the toilets, many unwanted and expired 
prescription drugs are deliberately disposed of via drains [95-
97]). Also, Richardson & Bowron [93] reported that most of the 
drugs like antiseptics and lotions are assumed acceptable to be 
diluted to low levels in crude sewage when sluiced away. 
Numerous papers have reported the distribution of different 
chemicals belonging to  different   therapeutic classes such as 
antibiotics, anti-inflammatory drugs, lipid regulators, beta-
blockers, β2 –sympathomimetics, antiepileptics, antidepressants, 
antineoplastics, contraceptives, tranquilizers, diagnostic contrast 
media, preservatives and sunscreen agents  in different media of 
the environment at the specific levels ranging from ngL-1 to µg 
L-1 [98-101].  Also reported at microgram levels in rivers were 
theophylline, erythromycin and tetracycline and some amounts 
of oestrogen from oral contraceptive in sewage systems excreted 
by human population [102]   
In Switzerland, about 4 tonnes/year of fluoroquinolones 
(antibacterial drug) are sold and 14 tonnes/year in Italy [90, 103, 
104], while 100 tons of annual drug prescription in Germany 
alone does not include several other pharmaceuticals that have 
been reported in aquatic samples in numerous papers ranging 
from ngL-1 to µg L-1 levels [87, 90,  104-106]. The recent 
analytical studies in UK   further show that some 
pharmaceuticals are incompletely removed from sewage 
treatment works and surface waters such as lakes, rivers and 
seas have some detectable pharmaceuticals present [84, 105, 
107-110].  
Table 2 lists data of the main pharmaceuticals monitored in 
German STWs as well as German rivers and streams with 10,11-
dihydro-10,11-dihydro-carbamazepine (DHH), a metabolite of  
antiepileptic carbamazepine having highest influent and effluent 
concentration of 4100 and 2600 ng L-1. 
Table 3, shows antiepileptic carbamazepine has highest 
concentration of 6300 ng L-1,  X-ray contrast media were 
between 11, 000-15, 000 ng L-1 [117]. About 31 pharmaceuticals 
and five metabolites were found in at least one sample of 40 
German rivers. Out of 69 target compounds, only 10 were found 
in drinking water [119]. The survey of exposure effects and 
other environmental relevance is in the literature reviews [83, 
120]. 
Commonly used illicit drugs and their metabolites in 
aqueous environment 
The term “illicit drug or drug of abuse” is normally used to 
describe those drugs that are controlled under the Misuse of 
Drugs Act, 1971. The legislation regulates controlled drugs into 
classes depending on the harm they cause, and there are various 
offences including the unlawful possession of a controlled 
substance [121]. The emerging risks with the prevalence and 
trends in the illegal production and abuse of illicit drugs have 
prompted the establishment of many International Agencies 
[122, 123] to monitor and conduct the risk assessments of the 
social, economic and environmental impacts the menace are 
eliciting, particularly in the consumer countries. The common 
classes of illicit drugs are cocaine, amphetamine, opioid, 
lysergic acid diethylamide (LSD), hallucillogen and 
cannabinoid, and by the hidden activity of their users, it has 
helped its purported widespread and continual escalating use 
[83]. The idea of Daughton [101] to use a non – intrusive 
approach to approximate the level of illicit drugs consumption at 
community level which was later demonstrated by Zuccato et al 
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[124] determined the levels of cocaine in waters and related the 
quantity to the amount of drug consumed by a local population. 
The approach apparently provided information needed by 
environmental scientists and appropriate authorities involved in 
the fight against the drug menace. It has been argued that the 
sewage systems constitute one of the potential routes those 
drugs enter the environment; other highly dispersed sources 
include disposals by drug and manufacturing laboratories [125]. 
Human metabolism of environmentally relevant drugs. 
In the human body, drugs are bio-transformed into one or 
more metabolites and after the loss of pharmacological activity 
the metabolites and unchanged parent drugs are eliminated from 
the body systemic circulation via urine or faeces. A number of 
parameters which include age, gender, ethnicity, patient and the 
time of administration have been associated to degree of 
metabolism. In Figure 9, the metabolism of drugs in the human 
body shows Phase I and Phase II reactions. The phase I 
comprises of oxidation reaction such as in aliphatic 
hydroxylation of ibuprofen and diclofenac, epoxidation of 
carbamazepine and ring oxidation of propranolol, while 
reductions, alkylations and dealkylations are other reactions.   
 
Figure 2:  Simplified scheme of dug metabolism in the 
human body [92] 
The conjugation reaction type occurs when polar molecules 
in Phase I transfer to the metabolites in Phase II such as the 
transfer of glucuronic acid to phenols, hydroxyls, caroxyls, 
thiols, amines and hydroxylamino groups. [92]. There is 
therefore interest in identifying the metabolites that may  pass 
on to the sewage, and those that might stay longer in the STWs 
and enter the environment through untreated water effluents or 
sewage biosolids.  
In the following sections, the metabolisms of the five major 
classes of illicit drugs found in various wastewaters are 
discussed. 
Human metabolism of cocaine 
Cocaine is extracted from the leaves of two species of coca: 
Erythroxylum coca and Erythroxylum novogranatense. The 
cocaine hydrochloride is normally formed after the alkaloids are 
precipitated with sodium carbonate and then dissolved in dilute 
HCl containing about 40% of cocaine, but when cocaine 
hydrochloride is extracted with ether in aqueous alkaline 
solution, it produces “free base” which contains 85-90% of pure 
cocaine [94,126]. The street cocaine used by addicts is often 
mixed or cut with a number of diluants [127], and these 
adulterants are sometimes the cause of poisoning. Cocaine is a 
powerful addictive stimulant drug with three common routes of 
administration: smoking, intravenously and intranasally 
(through the nose). Figure 10 shows only the compounds we 
determined in the results, however, cocaine is spontaneously 
metabolized by the action of pseudo cholinesterase and hepatic 
esterase to give ecgonine methylester (EME) with the loss of 
benzoyl group [128-131].  A non-enzymatic hydrolysis at pH 
above 6 converts cocaine to benzoylecgonine (BZE) by 
demethylation as its main metabolite. BZE can be detected in 
the urine 48 hours after cocaine administration with a urinary 
excretion half-life of 6-8 hours [132-133].  The N-demethylation 
of cocaine leads to norcocaine (NC) (the most toxic metabolite) 
by P450 enzymes and then metabolized to N-hydroxynorcocaine 
by brain FAD –containing mono- oxygenases [134-135]. 
Norcocaine can further be hydrolysed to benzoylecgonine. 
Cocaine undergoes trans-esterification by enzymatic reaction in 
the liver in the presence of alcohol to form cocaethylene (CE); 
which has been reported to be more toxic than cocaine [136]. 
When cocaine is smoked, anhydroecgonine methylester 
(AEME) is produced and through enzymatic hydrolysis get 
converted to anhydroecgonine (AE) or ecgonidine [137]. The 
other metabolites of cocaine (ecgonidine, norecgonidine 
methylester, p- hydroxyl-benzoylecgonine, and m- hydroxyl-
benzoylecgonine) found in human urine  have minor metabolic- 
pathways that involve  the aromatic meta- and para- 
hydroxylation of cocaine followed by partial hydrolysis to the 
corresponding HO-Be isomers [138]. About 1-9% of cocaine 
has been excreted unchanged in the urine with much higher 
proportion in acid urine; its metabolites are recovered in variable 
proportions which depend on the route of administration [139]. 
 
Figure 3: Degradation pathways of cocaine in the human 
body [140]. 
Human metabolism of amphetamine 
Among the drugs classified as amphetamines are 
amphetamines (AM), methamphetamines (MA, “speed”) and 
methylenedioxymethamphetamine (MDMA, “ecstasy or 
Adam”). They are usually taken orally but can be snorted, 
smoked or injected. They are addictive stimulant drugs that 
affect the central nervous systems among other risks of 
dependence and abuse. Other designer drugs are 
methylenedioxyethylamphetamine (MDE, “eve”) and 3, 4-
methylenedioxyamphetamine (MDA, “love pills”) [141]. 
The major metabolic pathway involves deamination of 
cytochrome P450 to para- hydroxyl amphetamine and 
phenylacetone, this later compound is oxidised to benzoic acid 
and excreted as glucuronide or glycine (hippuric acid) 
conjugates. Smaller amounts of amphetamine are also converted 
to norepheridine by oxidation. Although most enzymes involved 
in amphetamine metabolism have not been clearly defined, 
CYP2D6 is known to be involved with the formation of   4- 
hydroxylamphetamine [142-143] 
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Table 1:  Organic contaminants in sewage sludge [15 – 61]. 
Pollutants Sources/usages Analytes                        Matrix Ref 
Organochlorine Pesticides 
and  PCBs          
Agricultural control   of 
pests, transformer   fluids, 
plasticisers PVCs and  
artificial    Rubbers            
g-HCH, Aldrin,  Endrin, 
PCBs,   Dieldrin        
sewage            15, 16 
Chlorophenols & 
chlorophenoxy  acids                                                      
Herbicides 4-chlorophenol 
2-chlorophenol, 
2-chloro-6-MP 
 MCPA; 2,4-D                                       
Sewage 16-19 
Organophosphorus 
Compounds 
Pesticides   residues                            Sewage 20, 21 
Nitrosamines &  
Nitroaromatics 
Control nematodes              Dimethylnitrosamine; 
NDMA; NDEA; 
NPYR; NMOR. 
Sewage 21, 22 
Mineral oils                Engine oils, paints               Paraffine, alkybenzene  
cycloparaffine      
Sewage 23, 24                                                                                                
Alkylphenols Detergents, surfactants       4-alkylphenol; 
polyetho- xylates; 
4-nonylphenol (NP); 
Monoethoxylates 
(NP1EO); (NP2EO) 
Sewage 25, 26 
Lipids                          Petroleum hydrocarbon      Phosphatidyl serine,  
Phosphatidyl 
ethanolamine,     
Phosphatidyl choline       
Sewage            24, 27 
Acrylamide Monomer Coagulants   Polyacrylamide    Sewage 28 
Phthalates esters          Plasticisers bis-(2-
ethylhexyl)phthalate     
Sewage             29 
Organotin compounds Stabilisers in PVCs  
biocides,  foams               
Tributyltin oxide             Sewage   30-32 
Surfactants & 
Related residues    
 
Chlorobenzenes         
Detergents 
 
Paint removers                   
 
Linear alkylbenzene   
Sulphonates (LASs),   
 
chlorobenzenes 
Sewage 
 
Sewage 
 
33-38 
 
39-46 
 
Polychlorinated 
dibenzodioxins (PCDD)          
 Pulp bleaching Congener group Sewage 47-54 
Polycyclic-aromatic hydro 
carbons (PAHs)                 
Pyrolysis of organic 
materials.          
Naphthalenes Sewage 55-61 
 
Table 2: Occurrence of psycho-active drugs and beta blockers in STWs [116] 
 
Substances 
Influent Effluent 
LOQ 
[ng L-1] 
No of samples Max 
[ng L-1] 
LOQ 
[ng L-1] 
No of 
samples 
Max 
[ng L-1] 
Antiepileptics       
Carbamazepine 200 9 1000 100 9 1200 
DH-CBZ 100 7 30 50 8 30 
DHH 200 9 4100 10 9 2600 
Primidone 200 9 420 10 9 250 
Antidepressants       
Doxepin 200 9 100 10 9 190 
Opioids       
Oxycodon 200 0 - 10 0 - 
Dihydrocodeine 200 9 140 10 9 70 
Codeine 200 9 160 10 9 30 
Morphine 200 9 440 10 9 29 
Methadone 100 9 130 5 9 120 
Tramadol 200 6 470 10 6 370 
Tranquilizers       
Diazepam 200 0 - 10 0 - 
Nordiazepam 200 0 - 10 0 - 
Oxazepam 200 6 190 10 6 180 
Beta blockers       
Atenolol 100 9 910 5 9 370 
Sotalol 100 9 1300 5 9 1200 
Metoprolol 100 9 1200 5 9 1100 
Propranolol 5 9 70 3 9 60 
Bisoprolol 100 9 380 5 9 270 
Celiprolol 100 9 160 5 9 160 
Betaxolol 5 4 10 3 1 - 
Note: DH-CBZ (10, 11-dihydrocarbamazepine 
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Table 3: Pharmaceuticals in German STW effluents, rivers and streams [81, 105, 116, 117] 
                                                  
Analyte                                  
 
STWs    Rivers/streams  
LOQ 
(ng L-1)       
Number  STWs          Maximum   
(ng L-1) 
 
 
LOQ     
(ng L-1)               
Maximum   
 (ng L-1)             
Lipid regulator       
Bezafibrate                          250         49 4600  25 3100 
Gemfibrozil                         50        49 1500  10 510 
Clofibric acid 50 49 1600  10 550 
Fenofibric acid 50 49 1200  10 280 
Antiphlogistics       
Diclofenac 50 49 2100  10 1200 
Ibuprofen 50 49 3400  10 530 
Indomethacin 50 49 600  10 200 
Naproxen 50 10 520  10 390 
Ketoprofen 50 49 380  10 120 
Phenazon 100 30 410  20 950 
Acetylsalicylic acid 100 49 1500  20 340 
Salicylic acid 50 36 140  10 4100 
Betablocker       
Metoprolol 25 29 2200  10 2200 
Propranolol 25 29 290  10 590 
Betaxolol 25 29 190  10 30 
Bisoprolol 25 29 370  10 2900 
β2-Sympathomimetics       
Terbutalin 50 29 120  10 <LOQ 
Salbutamol 50 29 170  10 35 
Psychiatric drug       
Diazepam 30 20 40  30 <LOQ 
Antiepileptic       
Carbamazepine 50 30 6300  30 1100 
Antibiotics       
Clarithromycin 20 8 260  20 260 
Roxithromycin 20 10 1000  20 560 
Chloramphenicol 20 10 560  20 60 
Sulfamethoxazol 20 10 2000  20 480 
Trimethoprim 20 10 660  20 200 
Dehydrato-erythromycin 20 10 6000  20 1700 
X-ray contrast media       
Iopamidol 10 25 15000  10 2800 
Iopromide 10 24 11000  10 910 
Diatrizoate 10 25 8700  10 ca.100 
Iomeprol 10 12 3800  10 890 
Estrogens       
Estrone 1 38 70  0.5 1.6 
17β-Estradiol 1 38 3  0.5 <LOQ 
17β-Estradiol-17-valerate 4 38 <LOQ  2 <LOQ 
17α-Ethinylestradiol 1 38 15  0.5 <LOQ 
16α-Hydroxyestrone 1 15 5  0.5                  <LOQ 
 
Table 5: Sewage sludge disposal in England, 2008-2011 [196] 
 
 
 
 
 
 
*EfW = Energy from waste 
 
Table 6: Illicit drug metabolites of human origin detected in the environment* 
Compound    Human metabolites identified   in biological fluids    
[150, 225-242]                                                                                        
Human metabolites identified   in the aquatic environment 
[116158, 221, 243-251]                    
Amphetamine 
 
Amphetamine (AM)                                             
3, 4-methylenedioxyamphetamine (MDA) 
Methylenedioxymethamphetamine (MDMA) 
Methylenedioxyethylamphetamin (MDEA) 
Methylbenzodioxolylbutanamine (MBDB) 
Detected 
Detected 
Detected 
Detected 
Detected 
Mode of disposal %  Total disposed 
 2008/2009 2009/2010 2010/2011 Jan-Dec 2011 
Tonnes  % Tons % Tons % Tons % 
Land fill 
Incineration with EfW* 
Inicineration without EfW 
Recycled/Composted/Reused 
Other 
13784 
3325 
6 
10082 
198 
 50 
12 
0 
37 
1 
12490 
3610 
6 
10275 
255 
47 
14 
0 
39 
1 
11391 
3975 
5 
10588 
356 
43 
15 
0 
4 
1 
10135 
4577 
4 
10844 
404 
39 
18 
0 
42 
2 
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Metamphetamine (MA) 
p-hydroxy-metamphetamine  (p-OHMA) 
p-OHMA-glucuronide (p-OHMA-Glu) 
p-OHMA-sulfate (p-OHMA-Sul) 
Detected 
- 
- 
- 
Cocaine 
 
Cocaine (Cocaine) 
Benzoylecgonine (BE) 
Ecgonine methyl ester (EME) 
Cocaethylene (CE) 
Norcocaie (Nor- COC)                           
Ecgonidine 
nor-ecgonidine 
nor- ergonine methylester 
m-OH-benzoylegonine 
ecgonine 
ecgonidine methylester 
Detected 
Detected 
Detected 
Detected 
Detected 
- 
- 
- 
- 
- 
- 
Opiates 
 
Heroin 
Morphine 
Nor-morphine 
6-monoacetylmorphine (6-ACM) 
Morphine -3- glucuronide (M3G) 
Methadone 
2-ethylene-1,5-dimethyl 1-3,3-diphenylpyrolidene (EDDP) 
Ethyl morphine 
Detected 
Detected 
Detected 
Detected 
Detected 
Detected 
Detected 
- 
LSD 
 
Lysergicdiethylamide (LSD) 
Hydroxyl Lysergicdiethylamide (OH-LSD) 
Nor - Lysergicdiethylamide (Nor-LSD)                                                                            
Iso - Lysergicdiethylamide (Iso-LSD) 
2-oxo-3-hydroxy-LSD (2-Oxo-3-OH-LSD) 
Detected 
Detected 
Detected 
Detected 
- 
Cannabinoids 
 
∆9-tetrahydrocannabinol (THC) 
∆9-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) 
THC-COOH- glucuronide (THC-COO gluc.) 
Hydroxyl -THC- conjugate (OH-THC) 
Detected 
Detected 
Detected 
Detected 
* No identified microbial degradates in the literature 
 
Table 7: Assessment of the biodegradability of pharmaceutical chemicals [93, 111] 
Compound Test result 
Amitriptyline 
Ampicillin 
Aspirin 
Caffeine 
Chlorhexidine 
Clofibrate 
Codeine phosphate 
Dextropropoxyphene 
Ephedrine 
Erythromycin 
Ibuprofen 
Menthol 
Meprobamate 
Methyldopa 
Metronidazole 
Naproxen 
Paracetamol 
Phenylpropanolamine 
Sulphamethoxazole 
Sulphasalazine 
Tetracycline 
Theobromine 
Theophylline 
Tolbutamide 
Non-biodegradable 
Biodegradable 
Readily biodegradable 
Readily biodegradable 
Non-biodegradable 
Non-biodegradable 
Non-biodegradable 
Non-biodegradable 
Readily biodegradable 
Non-biodegradable 
Biodegradable 
Readily biodegradable 
Non-biodegradable 
Non-biodegradable 
Non-biodegradable 
Non-biodegradable 
Readily biodegradable 
Readily biodegradable 
Non-biodegradable 
Non-biodegradable 
Non-biodegradable 
Readily biodegradable 
Readily biodegradable 
Non-biodegradable 
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Table 8  Chromatographic (LC-MS/MS) methods for the determination of illicit drugs and human metabolites in water (2000-2011) 
Analytes             Matrix         Sample Preparation                                             LC                                                                    MS                     Method                
Ref.     
                                                ______________________________________  ____________________________________    
_____________(LOD/LOQ)  
                                                   Volume            Extraction          Method           C’graphic          Mobile            Detector            Acq. 
                                                   (mL)                                            Recovery (%)  Column             Phase        (Interface)        Mode                (ng L-
1)  
3 Cocaine: 
(CO, BE,  
EME)                                                                                                                        
WW 
 SW 
100 SPE (Oasis, 
HLB, 500 mg)                                  
73-
96
Zorbax Extended 
C18(2.1mm x 50mm x 
3.5µm) HILIC: Rx-SIL 
(2.1 x 150mm,5µm)       
250 µL/min. 
A:H2O/AcN 
(92:2),10mM 
NH4HCO2. (pH 3). 
B: ACN. 
ITMS 
(ESI+) 
MRM     2-
4WW     
    
20SW        
[219] 
 
1Cocaine 
1 Opoiod.    
1Cannabiniod 
3 ALC.                          
WW - SPE (Oasis, 
MCX, 200mg) 
- HPLC: XTerraMS C18 
(100mm x 
2.1mm,3.5µm) 
250 µL/min.  A: 
0.1%  in H2O. B: 
AcN                                                                                                               
QqQ  
(ESI+) 
SRM - [270] 
5 Cocaine 
4 ALCs  
3 Opiods   
1Cannabiniod                                     
SW 250 
mL     
SPE (Oasis, 
MCX,60mg)       
96-
105 
97 
10 
85-
90 
69-
84 
HPLC: XTerraMS 
C18(100mm x 
2.1mm,3.5µm) 
250 µL/min.   A: 
0.1%  in H2O. B: 
AcN                                                                                                               
QqQ 
(ESI+) 
SRM 0.02-
0.05     
0.01-
0.35 
0.02-
0.28 
0.14-
0.36 
[158] 
2 Cocaine SW 
WW 
100 
mL 
500 
mL 
SPE (Oasis, 
HLB, 500 mg)                         
- HILIC: Zorbax Rx-SIL 
(2.1 x 150mm, 5µm)         
- ITMS 
(ESI+) 
MRM ≤ 20            [158] 
2 Cocaine SW 500 
mL 
SPE (Oasis, 
MCX, 60mg) 
90 HPLC: A Luna  C18   
(50mm x 2mm i.d, 3 
µm)                                                                 
250 µL/min A: 
0.1%  in H2O. B: 
AcN                                                                                                               
- MRM - [124] 
 
Analytes             Matrix       Sample Preparation                                             LC                                                                    MS                          
Method                 Ref.     
                                                ______________________________________  ____________________________________    ______________  
(LOD/LOQ) 
                                                     Volume          Extraction        Method            Chromatographic Mobile       Detector          
Acq. 
                                    (mL)                                          Recovery (%)   Column  Phase       (Interface)       Mode                   (ng L-
1)     
3 Cocaine 
1ALC 
3 Opiods 
1LSD 
                                                                        
WW 500 
mL    
SPE 
(Strata- 
XC, 
200mg) 
50-
65 
HPLC: Phenomenex 
Onyx C18  (200 x 
3.0mm                                      
   36-120           [244] 
5 ALCs   
5 Cocaine 
5 Opiods   
1Cannabiniod                                                                                                                 
WW 50 
mL      
SPE 
(Oasis, 
MCX, 
60mg)
50-
105 
HPLC: XTerraMS 
C18(100mm x 
2.1mm, 3.5µm)     
250 µL/min 
A:CH3COOH/ H2O. B: 
AcN A2: 0.05% TEA/ 
H2O  
QqQ 
(ESI+) 
MRM 300 
pg/Lwwinf    
1 ng/L 
wweff
 
[248] 
           
2 Cocaine SW 
WW 
100 
mL   
500 
mL       
SPE 
(Oasis, 
HLB, 500 
mg)                         
- Zorbax Rx-SIL (2.1 
x 150mm, 5µm)                                                            
- ITMS MRM 
(ESI+) 
20 [271] 
           
1 ALC WW 250 
mL      
SPE 
(Oasis,  
HLB, 200 
mg)                       
36-
49                 
HPLC:Varian 
Pursuit XRs C18 
(100mm x 2.0mm, 
3µm)              
A:water/0.5%  HCOOH                                                
B: 82% CH3OH/ 18% 
AcN/0.5% HCOOH                      
- Scan    
(CID) 
0.25-5.0          [247] 
           
5 ALCs    
2 Cocaine.   
1LSD 
1Opiod                                                    
WW 100 
mL 
SPE 
(Oasis 
HLB, 200 
mg)                           
70-
110          
UPLC:Acquity BEH 
C18    (100mm x 
2.1mm, 1.7 µm)           
A: AcN/0.1% HCOOH. 
B: 30mM HCOOH/ 
NH4HCO2                                               
QqQ 
(ESI+) 
- 5 - 850       [272] 
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Table 8  LC-MS/MS methods for the determination of illicit drugs and human metabolites in water (2000-2011) 
Analytes               Matrix       Sample Preparation                                             LC                                                                    MS                         
Method              Ref.     
                                                ______________________________________  ____________________________________    
_______________(LOD/LOQ) 
                                                     Volume          Extraction        Method            Chromatographic Mobile       Detector          
Acq. 
                                    (mL)                                         Recovery (%) Column                 Phase       (Interface)       Mode                 
(ng L-1) 
1 ALC 
2 Cocaine.                                    
SW 100 
mL
SPE (Oasis,  
MCX,60mg)                                         
65-
106   
UPLC: Acquity 
BEH C18 (1.7µm, 
1 mm x  100mm)                                                
A:94.5% H2O. 5% MeOH, 
5% CH3COOH (pH 2.8)  
B:99.5% MeOH + 0.5% 
Acetic                         
QqQ 
(ESI+) 
MRM 0.3-
50             
[259] 
           
8 Opiods   
2Cannabiniod   
SW  
WW 
200 
mL    
SPE (Oasis, 
HLB, 200 mg)                          
40-
70
UPLC: Acquity 
BEH C18 (1.7µm, 
1 x   100mm)           
A: MeOH 
B: 5 mM NH4HCO2 
QqQ 
(ESI+) 
SRM 0.1-
25 
[258] 
           
8 Opiods   
2 
Cannabiniod    
SW 
WW 
50 
mL      
SPE (Oasis,  
MCX,(150mg)          
69-
94% 
UPLC: Acquity 
BEH C18 (1.7µm, 
2. 1 mm x50mm)                                                      
A: MeOH  B: 5 mM 
NH4HCO2  + 1% formic 
acid
QqQ 
(ESI+)                                                
SRM - [247] 
           
Acq. Mode - Acquisition mode- SRM, Selected reaction monitoring; CID, Collision-induced dissociation. 
Detector and Interface used – QqQ, Triple quadrupole; ITMS, Ion Trap mass spectrometry, ESI, Electrospray ionization. 
MeOH – Methanol; TEA, Triethylamine; NH4HCO2, Ammonium acetate; AcN, Acetonitrile, H2O, Water.                 
WW, Wastewater;  SW, Surface water; WWinff, Waste water influent;  WWeff, Waste water effluent.  
RPLC, Reversed-phase liquid chromatography; UPLC, Ultra- performance liquid chromatography; HILIC, Hydrophilic interaction 
chromatography. 
 
Table 9. Solid Phase Extraction (SPE) protocols in wastewater pre-treatment 
Protocols 
Types    Sorbent materials              Conditioning Washing Elution    Ref 
 
Isolute, pH®   
(1000 mg/6 mL)                
 
Silical treated with phenyl 
groups in which silanol 
group are end-capped.                                                   
 
2 mL of MeOH and 6 mL  
of milli-Q water, sample  
loading at (pH 6)                               
 
6mL of 5% MeOH  in 
water, drying in  in 
vacuum for 15 min                   
 
2 x 4 mL of 5% NH3 in 
acetone              
 
[219] 
      
Oasis, MCX® 
(500 mg/6 mL )                 
Polymeric sorbent with 
strong  cation –exchange 
sulfonic group located on 
surface of poly(Divinyl 
benzene-Co-N-vinyl py 
rrolidone) copolymer .                                                                                              
6 mL of MeOH , 3mL of   
milli-Q water and 3 mL of 
water at pH 2, sample load- 
ing at pH 2.                                                                                                          
3 mLof milli-Q water  at 
pH 2, dryingfor 15  min. 
under vacuum       
6 mL of MeOH   and 6 
mL of 5% NH3  in 
MeOH                                                 
[124, 159, 
186, 259, 
270] 
 
      
Bond Elut 
Certify®   
(300mg/6 mL)                       
Lipophilic and strongly 
cationic  properties                                           
3 mL of MeOH and 3 ml  
of milli-Q water, sample  
Loading at pH 6.                                  
2 mL of of milli-Q H2O 
at at pH 2, and 3 mL of  
MeOH, drying for 15 
min under vacuum                             
2 x 4 mL of  80:   20 
DCM/isopropanol 
mixture with 2% NH3        
[225,226] 
      
SCX®  (500 mg/6 
mL)           
- 2 mL of MeOH, I mL of   
milli-Q water and 1 mL of 
0.25 M phosphate   buffer 
(pH 3), loading at pH 3                                                         
I mL of 0.25 M 
phosphate (pH 3), 0.5 
mL of  0.1M acetic acid 
and  1 mL of MeOH, 
drying  for 30 min             
1.5 mL of 3%  NH4OH 
in 1.5 mL of  MeOH                
[258] 
      
Phenomenex 
Strata-X™   (200 
mg/6 mL)                                                                               
- 2 x 6 mL of MeOH and   2 
x 6 mL of H2O, sample 
loading at pH 6.                                   
50 mL of 10% MeOH in 
100 mM formic acid + 
500 µL of acetic  acid, 
drying for 30                                     
10 mL of 5% v/v 
NH4OH in 1:1 acetone: 
ethyl acetate                               
[244]           
      
Strata-XC™ 
(200mg/6mL)          
-        -same-                               -same-                                    -same-                                    [244] 
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Protocols 
Types    Sorbent materials                            Conditioning Washing Elution    Ref 
Chrolut, ENV® 
(500 mg/6 mL)                              
Hyper-crosslinked polystyrene-
divinyl benzene polymer based.                                                                       
3 mL of MeOH and 3 mL    
of milli-Q water, sample
loading. 
                
air through the 
column for 1 hr.      
5 mL of MeOH                        [82]
Isolute, ENV® 
(500 
 mg/6 mL)                                
Hydrophobic sorbent with  
hydroxylated polystyrene  
divinyl benzene copolymer                                              
2 mL of MeOH and 6 mL  
of milli-Q water, sample  
loading at pH 6               
6 mL of 5% MeOH   
in water, drying 
under vacuum for 15 
min.            
2 x 4 mL of  
MeOH.                          
[219] 
      
Chromabond, 
Easy (500 mg/6 
mL)                         
Bifunctional polystyrene   
divinyl benzene copolymer                                 
5 mL of hexane, 5 mL of 
ethyl acetate, 10 mL of 
MeOH and 1 mL of  
Milli- Q water.                
5 mL of milli-Q 
water   drying under 
vacuum for 15 min.        
2 x 4 mL of  
MeOH                          
[219,271] 
      
Oasis, HLB®  
(500  
mg/6 mL)                           
Divinylbenzene/N-vinyl    
pyrrolidone) copolymer   with 
hydrophilic/lipo philic properties                                                 
3 mL of  MeOH and 3 
mL   of milli-Q water, 
sample loading at pH 6                                 
3 mL of 5% MeOH  
in milli-Q water  
drying under vacuum  
for 15 min                         
2 x 4 mL of  
MeOH                         
[219,243]   
      
Oasis, HLB®  
(500 
 mg/6 mL)                           
-same-                                               5 mL of hexane, 5 mL of   
ethyl acetate, 10 mL of   
MeOH and 1 mL of  
Milli-Q water                     
5 mL of milli-Q 
water drying under 
vacuum      for 15 
min.       
2 x 4 mL of  
MeOH                       
[83,243] 
      
Isolute ,C18 
(EC)® (500 mg/6 
mL)                             
Strongly apolar and lipo- philic 
based on octadecyl   silica with 
end capping of   free silanol 
group.                                                             
2 mL of MeOH and 6 mL 
of  milli-Q water, sample   
loading at pH 6                                     
6 mL of 5% MeOH  
in milli-Q water 
drying under vacuum  
for 15 min.                            
2 x 4 mL of  
5% NH3 in  
acetone                         
[219,272] 
      
Oasis, Max (60 
mg)                                                  
Strong anion-exchange mixed 
mode polymeric           
2 mL of MeOH and 2 mL  
of 2% HCOOH (pH 2.1)              
2 mL of 2% 
HCOOH/   H2O, 
wrapped in 
aluminium          
1 mL of MeOH 
and 2 mL of  
5%  NH4OH in 
MeOH.                   
[259] 
 
Protocols 
Types    Sorbent materials                            Conditioning Washing Elution    Ref 
 sorbent built  upon HLB copolymer  
(application: acids)                                                                                  
 foil and stored in 
a freezer until 
eluted.       
  
      
Oasis, WCX (60 
mg)                                                
Weak cation-exchange mixed mode 
polymeric sorbent built upon HLB 
copolymer (application: strong bases). 
         
2 mL of MeOH 
and 2 mL  of 2%  
HCOOH (pH 2.1)                                   
-same-                                   1 mL of MeOH and 2 
mL of  5%  NH4OH 
in MeOH 
[259] 
Oasis, WAX  
(60 mg)                                             
Weak anion- exchange mixed mode 
polymeric sorbent built upon HLB 
copolymer (application: strong acids). 
       
-same-                                   -same-                                   -same-                                   [259] 
Chromabond, 
C18  
(200 mg).                                      
Silical-based, endcapped sor-bent (non-
polar compounds).                
-same-                                   -same-                                   -same-                                   [259] 
      
Isolute, HCX 
(200 mg)     
Weak anion- exchange mixed mode (non-
polar and basic analyte). 
-same-                                -same-                                -same-                                [259] 
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Table 4  Survey of illicit drugs and pharmaceuticals concentration in wastewaters. 
Analytes Matrix Influent 
 (ng L-1 ) 
Effluent  
(ng L-1 ) 
Surface Water  
(ng L-1 ) 
Ref 
Cocaine 5 STPs, Spain 225.0  47 10 [158] 
 5 STPs,  Belgium 22 -678 - 1.2 - 26 [219] 
 37 STPs, Belgium 32 – 753 - - [158] 
 3 Rivers, Italy - - 0.3 – 44 [186] 
 5 STPs, Ireland, UK 489 ± 117 25 - 248 ± 20 0 – 33 ± 11 [244] 
 Eastern Spain 370 – 1000.24 30 – 560 - [258] 
 30 STPs, Belgium 09 – 683 - - [245] 
 2 STPs, Italy 218.4 – 421.4  0.9 – 10.7 ± 3.2 - [159] 
 4 STPs; River Po. 42 – 120 - - [124] 
 42 STPs, NE Spain 04 – 4700 01 – 100 - [272] 
 Barcelona, Spain 2.40  - - [246] 
      
Benzoylecgonine 5 STPs,  Spain 2307.0 - 111 [158] 
 5 STPs,  Belgium 82 – 1 898 928 44 - 191 [219] 
 37 STPs, Belgium 46 –2258 - - [186] 
 3 Rivers, Italy 2.2 – 183 - - [186] 
 5 STPs, Ireland UK 290 ± 11 22 - [244] 
 Eastern  Spain 150 – 1000.5 22 ± 4 – 31 ± 18 - [258] 
 30 STPs, Belgium 37 – 1550 6.0 – 7.9 - [245] 
 2 STPs, Italy 547.4 -197.2  - - [159] 
 4 STPs; River Po. 420 - 750 0.92 – 100.3 ± 28.6 - [124] 
 42 STPs, NE Spain 09 – 7500 - - [272] 
  Barcelona, Spain 5.24 01 – 1500 - [246] 
 12 STPs, Germany 65± 5 77± 9 71 [276] 
 
Analytes Matrix Influent 
 (ng L-1 ) 
Effluent  
 (ng L-1 ) 
SW  
(ng L-1 ) 
Ref 
Nor- BE 3 Rivers, Italy - - 0.2 – 8.4 [186] 
 Eastern  Spain 150 - 430 30 – 170 - [258] 
 2 STPs, Italy 18.8± 5.6 – 36.6 ± 7.8 <LOQ – 7.5 ± 2.9 - [159] 
 
Cocaethylene 2 STPs, Italy 5.9 ± 2.6 – 11.5 ± 5.1 0.2 ± 0.5 - [159] 
 Barcelona, Spain 77.5– 78.5±33.2 1.71– 4.2± 1.2 4.63 [246] 
 3 Rivers, Italy - - 0.07 – 0.2 [186] 
 
Nor-cocaine 
 
3 Rivers, Italy 
Eastern Spain 
2 STPs, Italy 
 
- 
0.15 – 0.43 
4.3 ± 0.9 – 13.7 ± 5.3 
 
- 
0.03 - 0.17 
0.7 ± 0.5 
0.15 – 3.6 
- 
- 
[186] 
[258] 
[159] 
Amphetamines 
 
 
 
 
 
 
Metamphetamines 
 
 
 
 
 
 
 
 
MDA 
 
 
 
3 Rivers, Italy 
Eastern Spain 
2 STPs, Italy 
42 STPs, NE Spain 
Barcelona, Spain 
5 STPs,  Spain 
 
5 STPs, Nebraska USA 
3 Rivers, Italy 
Eastern  Spain 
2 STPs, Italy 
42 STPs, NE Spain 
3 STPs, USA 
Barcelona, Spain 
Murray, USA 
 
42 STPs, NE Spain 
3 Rivers, Italy 
Eastern  Spain 
2 STPs, Italy 
5 STPs,  Spain 
 
- 
1400 
5.4 – 14.7± 10.6 
03 - 6880 
20.8 – 41.1± 9.1   
15 
 
1.3 ± 0.1 – 1.4  
 0.1 – 62.6 ± 13 
- 
<500 
3 - 277 
15 ± 2 – 66 ± 14 
4.8 – 18.2 ± 5.8 
6.0 - 34 
 
03 - 266 
- 
500 - 1400 
4.6 ± 7.3 – 8.7 
03 - 266 
 
- 
110 – 210 
2.8 
04 - 2100 
0.45– 2.2 ±  0.1 
<1.0 
 
35.0± 7.3 
- 
<100 - 540 
<1.11 – 3.5 ± 2 
3 - 90 
0.8 – 1.3 
2.1 – 6.3  ± 0.6 
03 - 7 
 
01 - 200 
- 
41.0 – 68.0 
0.9 ± 1.9 – 1.1± 1.5  
1 - 200 
 
<0.65 
- 
- 
- 
2.84 
<0.8 
 
- 
<0.41 – 1.7 
- 
- 
- 
- 
2.87 
- 
 
- 
3 ± 0.3 – 4 
- 
- 
- 
 
[186] 
[258] 
[159] 
[272] 
[246] 
[158] 
 
[160] 
[186] 
[258] 
[159] 
[272] 
[160] 
[246] 
[247] 
 
[272] 
[186] 
[258] 
[159] 
[158] 
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Analytes Matrix Influent  
(ng L-1 ) 
Effluent  
 (ng L-1 ) 
SW  
(ng L-1 ) 
Ref 
MDMA 
 
 
 
 
 
 
 
 
MDEA 
 
3 Rivers, Italy 
Eastern  Spain 
2 STPs, Italy 
5 STPs,  Spain 
STP, Italy 
Barcelona, Spain 
Murray, USA 
42 STPs, NE Spain 
 
5 STPs,  Spain 
2 STPs, Italy 
STP, Italy 
STP, Spain 
42 STPs, NE Spain 
- 
326 – 2700.5 
13.6 – 14.2  
91 
2 - 598 
133– 135.13 ± 29.8 
<1.0 – 10.0 
2 - 598 
 
27 
4.19 – 1.5 ± 3.8 
6 - 114 
<500 
06 - 114 
- 
100 – 210.2 
4.4 ± 3.7 – 5.1± 3 
67 
2 - 267 
8.2– 14.8 ± 2.2 
- 
2 - 267 
 
<2.1 
<1.64 
12 
<100 
12 
1.1 – 4.0 
- 
- 
3.5 
- 
129 
- 
- 
 
- 
- 
- 
- 
- 
[186] 
[258] 
[159] 
[158] 
[272] 
[246] 
[247] 
[272] 
 
[158] 
[159] 
[258] 
[272] 
[272] 
Opiates 
Heroin 
 
 
Morphine 
 
 
 
 
 
  
 
Nor-morphine 
 
 
6 ACM 
 
Barcelona Spain 
STP, Italy 
 
5 STPs, NE Spain 
3 Rivers, Italy 
5 STPs, Ireland 
2 STPs, Italy 
Barcelona, Spain 
12 STPs, Germany 
STP, Italy 
 
5 STPs, NE Spain 
1 STP, Italy 
 
3 Rivers, Italy 
2 STPs, Italy 
Barcelona, Spain 
 
2.4 
20.0 
 
25.9 – 96.7 
- 
874 ± 86 
83.3– 204.4  
68.1 – 162.9 ± 20.0 
123 ± 6 
7.1 – 96.7 
 
30.7 
<25 
 
- 
10.4± 4.8 – 11.8 ± 8.5 
8.4 – 12.8 ±3.1 
 
1.2 
<20.0 
 
20.9 – 81.1 
- 
452  
5.5 ± 11.1 
21.8 ± 3.0 
9.0 ± 1.2 
0.1 – 8.1. 
 
- 
<2.5 – 3.7 
 
- 
- 
2.5 – 3.6 ± 0.5 
 
- 
<1.5 
 
- 
3.5 - 38 
- 
1-2L 
3.25 
83 
4.8 – 6.3 
 
- 
<12..5 
 
0.93 
- 
- 
 
[246]  
[247] 
 
[247] 
[186] 
[244] 
[159] 
[246] 
[246] 
[247] 
 
[247] 
[247] 
 
[186] 
[244] 
[246] 
 
 
Analytes Matrix Influent 
 (ng L-1 ) 
Effluent  
 (ng L-1 ) 
SW 
 (ng L-1 ) 
Ref 
 
 
 
M3G 
 
Methadone 
 
 
 
 
 
Codeine 
 
 
 
Nor-codeine 
 
6 Acetyl codeine 
 
EDDP 
 
12 STPs, Germany 
STP, Italy 
 
2 STPs, Italy 
 
5 STPs,  Spain 
3 Rivers, Italy 
2 STPs, Italy 
12 STPs, Germany 
 STP, Italy 
 
5 STPs, NE Spain 
3 Rivers, Italy 
12 STPs, Germany 
 
5 STPs, NE Spain 
 
3 Rivers, Italy 
 
3 Rivers, Italy 
5 STPs, Ireland UK 
2 ST1 STP, Italy 
STP, Italy 
8.4 – 12.8 ±3.1 
102 ± 14 
 
2.5 ± 7.1 – 18.1 ± 30 
 
4.0 – 239 
- 
11.6± 1.7 – 49.7 ± 9.6 
123 ± 6 
4 – 23.9 
 
18.1 – 119.7 
- 
80 ± 5 
 
5 – 68.0 
 
- 
 
- 
9.0 – 206 ± 10 
19.8 ± 3.1 – 91.3 ± 19.2 
4.5 – 41.3 
0.9 ±1.2 
<3.1 
 
<0.48 
 
4.0 – 24.7 
- 
9.1 ± 0.5 – 36.2 ± 2.8 
9.0 ± 12 
2 – 2.7 
 
3.1 - 397 
- 
7.7 ± 8 
 
15.5 – 22.9 
 
- 
 
- 
- 
22.6± 0.6 – 72.1± 8.7  
4.9 – 56.7 
83 
<0.9 – 3.4 
 
- 
 
- 
4.9 – 10.1 
- 
83 
4.9 – 10.1 
 
- 
1.0 - 51 
90 
 
- 
 
<0.31 
 
9.9 – 18.0 
- 
- 
9.61 – 17.5 
[246] 
[277] 
[247] 
[159] 
 
[247] 
[186] 
[159] 
[277] 
[247] 
 
[247] 
[186] 
[277] 
 
[247] 
 
[186] 
 
[186] 
[244] 
[159] 
[247] 
THC 
 
 
 
 
THC-COOH 
 
 
OH- THC 
 
5 STPs, NE Spain 
2 ST1 STP, Italy 
Barcelona, Spain 
 STP, Italy 
 
3 Rivers, Italy 
STP, Italy 
5 STPs, NE Spain 
Barcelona, Spain 
 
11.3 – 31.5 
62.7 ± 5 – 91.2 ± 24.7 
4.3– 21.03 ± 7.8 
8.3 – 31.5 
 
- 
12.5 – 96.2 
37.8 – 96.2 
8.4 – 46.3 
 
- 
<0.94 – 7.2 ± 3.7  
8.4 ± 3.8 – 11. 23 
<8.3 
 
- 
12.5 
14.8 – 48.1 
4.8 – 15.3 
 
- 
- 
2.65 
<7.0 – 13.6 
 
0.48 -3.7  
16.4 – 34.1 
- 
10.7 
 
[247] 
[159] 
[246] 
[247] 
 
[186] 
[247] 
[247] 
[246] 
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Figure 4: Main metabolites of 3, 4-
methylenedioxymethamphetamine (MDMA) in urine [144]. 
Human metabolism of opiates. 
Opium comes from the opium poppy (papaver 
somniferum), a conjugated juice from the unriped capsule. It is 
an ingredient in morphine, codeine and theobaine. Several 
illegal drugs are produced from the opium poppy and the 
common ones are morphine and heroin, while 6-
monoacetylmorphine/ and morphine are their related 
metabolites. The phenolic hydroxyl at position 3, the alcoholic 
hydroxyl at position 6 and the nitrogen atom plays important 
roles in morphine metabolism.  
Figure 12 only show how heroin (diacetylmorphine) 
degradation pathways to produce main metabolites that we 
determined in the current work. But different morphine 
conjugates may arise from the actions of different enzymes, this 
emphasises the complexity of morphine metabolism [145]. 
Approximately 90% of an administered dose of morphine is 
excreted in the urine only about 10% is excreted as unchanged 
morphine. Morphine -3- glucuronide (M3G) is the major 
metabolite, while Morphine -6- glucuronide (M6G) is a minor 
one [146], and nor- morphine and nor-morphine-6-glucuronide 
have also been found in human urine and detected in 
wastewaters [Table 4]. Other minor metabolites  like codeine (3-
O-methylmorphine) and morphine- N- oxide have been 
identified in the urine of chronic users [147].  
 
Figure 5:  Degradation pathways of heroin and its main 
metabolites in living organisms. [150]. 
 
 
Human metabolism of Lysergic Acid Diethylamide (LSD) 
Lysergic acid diethylamide is a compound derived from 
ergot alkaloids, a powerful hallucinogenic drug commonly sold 
as “acid” on the street as a drug of abuse. It is a non-addictive 
drug that comes in tablets or blotting paper, though liquid LSD 
is also available [148]. The drug is quickly metabolized in the 
body, where it is dispersed in the biological fluids in very low 
concentration and very small amount of the original dose is 
eliminated in the human urine [149]. In Figure 13, the following 
LSD metabolites have been identified in human biological 
fluids: 13-hydroxy-LSD, 14-hydroxy-LSD, N-demethyl LSD, 2-
oxo-LSD, and 2-oxo-3-hydroxy-LSD [121-123]. The main 
metabolite of LSD is 2-oxo-3-hydroxy-LSD and 13- and 14- 
hydroxyl-LSD are excreted as glucuronide conjugates in urine 
[151]. In a review paper of Reuschel et al [152], evidences 
supporting a much higher concentration of 2-oxo-3-hydroxy-
LSD in human urine of LSD users than the parent drug and 2-
Oxo-LSD concentrations were reported. The iso-LSD and LSD 
exist as stereoisomers in illicit preparations and therefore iso-
LSD is not a metabolite, it’s frequently found in urine as a main 
contaminant of LSD [153]. Additional metabolites have also 
been identified in the laboratory animals but are yet to be found 
in human fluids [154]. The LSD compounds were however not 
studied in the current work. 
 
Figure 6:  Lysergic Acid Diethylamide and metabolites in 
human fluids [168] 
Human metabolism of Cannabinoids 
The cannabinoids, of which the most important one is 
tetrahydrocannabinol (THC) is the active chemical in cannabis 
sativa L, other active constituents are cannabidiol and 
cannabinol. Cannabis is commonly known as the source of the 
‘marijuana’ drug and for centuries, this plant has been widely 
cultivated around the world for its fibres. The cannabinoids are 
non-polar compounds with low solubility in water but are 
soluble in fat, alcohol and many organic solvents, they are self-
administered by smoking. The volatilized fractions are inhaled 
to give physiological effects. It is non-addictive and there are no 
withdrawal symptoms but one of the common side-effects of its 
use is making the user drowsy with reduced concentration and 
short term memory [155]. About 66 types of cannabinoids have 
been isolated from the cannabis plant but three of them have 
received most attention from researchers as a result of their 
natural prevalence. These are: phytocannabinoids (obtained 
from cannabis plant), synthetic cannabidiols (prepared from 
laboratory) and endogenous cannabinols (obtained from the 
body of humans and animals).  
On ingestion, the cannabinoids are metabolized in the liver, 
especially by cytochrome P450 mixed-function oxidase, mainly 
CYP2C9. It is stored in the fat where ∆9-THC is metabolized to 
11-hydro-∆9-THC, which is metabolized to 9-carboxy-THC 
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[156], but the metabolism of THC is still not properly 
understood. 
Figure 14 shows the structure of ∆9-tetrahydrocannabinol 
(THC) and its metabolites in human urine [144]. The main 
metabolite is ∆9-tetrahydrocannabinol-9-carboxylic acid (THC-
COOH) and it is excreted as glucuronide-acid conjugate THC-
COOH- glucuronide) [157], the metabolites can be detected in 
the body after weeks. It appears that the illegal status of the 
plant in most countries affected its systematic studying. 
 
Figure 7: Major metabolites of ∆9-tetrahydrocannabinol 
(THC) in urine [168]. 
Sewage Treatment Works as transport routes of pollutants. 
Conventional sewage treatment works are the most 
significant routes through which the drugs enter the environment 
via untreated sewage and domestic sewage treatment systems. 
The ingested chemicals and associated metabolites are excreted 
via faeces and urine and passed onto sewage treatment systems. 
Discharges from manufacturers, commercial, domestic and run-
off areas of unwanted and unused chemicals to the domestic 
sewage system are other major sources. Sewage sludge is the 
remaining residues after sewage treatment and the treated 
sewage sludge has several valuable properties which are 
agriculturally relevant; these include soil building potential 
giving it a strong hold, availability of nutrients and valuable 
trace elements essential to animals and plants, an efficient and 
sustainable alternative source to inorganic fertilisers and mineral 
fertilisers such as phosphate, and soil nutrient recovery through 
slow release of nitrogen. 
Residues of pharmaceutical and illicit compounds have 
been found in surface waters in concentrations from ngL-1 to 
ugL-1 in many countries with the levels and distribution of these 
illegal compounds as found in wastewaters reported in Spain, 
Belgium, Italy, Germany, UK and USA [124, 158-167]. Apart 
from the active sludge processes, percolating filters, nitrification 
and de-nitrification facilities, investigations into the treatment 
technologies for the potential removal of drug residues and other 
organic compounds from the effluents of STWs have 
additionally identified ozonation [168-170] and membrane 
bioreactors (MBR) [171, 172] as biological means to provide 
improved potential in removing trace pollutants from the urban 
wastewaters. Microbial degradation has been suggested as the 
most important removal process in the sewage treatment works 
and with the continuing extensive studies on the metabolism and 
transformation of pharmaceuticals and other organics in humans 
and mammals, the microbial biodegradation pathways of some 
these chemicals, the persistence of their products and likely 
toxicity would largely be known [173]. Figure 16 below 
illustrates a typical interplay of complex physical, biochemical 
and transformational routes of pollutants in STWs and each 
transport route depends on the nature of influents [173-179].  
 
Figure 16: Organic contaminant fate and distribution in the 
environment [183] 
The microbial degradability of the illicit drugs in the 
sewage as well as their degradation pathways has not been 
reported. However, small studies on selected pharmaceuticals 
with the identification of some microbial degradates suggest that 
similar processes are likely to affect the illicit drugs [176-178].  
In 2009, the understanding of the STWs systems and the 
degradation processes involved were observed by Kasprzyk-
Horden et al [179] on selected pharmaceuticals and illicit drugs 
(cocaine, benzoylecgonine and amphetamine) where the 
differences in the performance of activated sludge and trickling 
filter on a 5-month monitoring program was undertaken from 
two different STWs in South Wales, UK.  However, the choice 
of sampling points was just to verify the removal efficiency of 
the two contrasting STWs and the work recorded over 85% 
removal efficiency of most drugs with STW utilising activated 
sludge compare to less than 70% reported for trickling filter.  
However, for the first time, direct measurement of the illicit 
drug removal rates in laboratory (batch) studies would carried 
out to  improve upon the understanding of the degradation rates 
of cocaine (COC); benzoylecgonine (BZE); heroin (HER); 6- 
monoacetylmorphine (6-MAM); morphine (MOR) and 
diazepam (Diaz) under different conditions to obtain removal 
rates.  The capabilities of the current experimental batch data in 
generating removal rates of drugs would be applied in mass 
balance calculation to improve influent measurement. 
 Also, no publication to our knowledge has been found on 
the ecotoxicological impacts of chronic exposure of illicit drugs 
and their metabolites as the STWs procedures cannot effectively 
remove all the drugs or polar compounds due to their 
hydrophobic/lipophilic character [111]. Apart from 
volatilisation, hydrolysis (abiotic) and biodegradation 
(biological processes), physical-chemical adsorption of polar 
compounds onto the biosolids surfaces also occurs. The 
interaction of compounds with high adsorption coefficients in 
particular determines the extent of the removal. Natural solids 
like clay, sediment and micro-organisms and added solids (e.g. 
active carbon, coagulants) facilitate STWs removal processes 
[184]. Those adsorbed on solids and passed as sludge enter the 
environment when spread on agricultural lands as manure and 
the compounds continue in the ecosystems or are possibly 
leached into underground waters; while those with low 
adsorption coefficients are released as effluents into the 
receiving waters.
  
The removal of organic compounds is often 
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incomplete in most municipal STWs, the sewage-sludge and 
effluent waters are therefore the primarily routes at which these 
chemicals enter the environment. Apart from the biodegradation, 
chemical degradation and sorption processes in typical STW 
details of which are not well understood because of the complex 
mixtures present are the other main removal processes during 
the wastewater treatment. The physicochemical properties of the 
contaminants ultimately determines their extent of persistence, 
toxicity and potential environmental effects after the sewage-
sludge disposal to agricultural lands or effluents waters disposed 
of to seas.  
The existing priority substance classifications by the 
European Communities Priority Substances Directive 
notwithstanding [185], the emerging priority contaminants 
groups like ‘illicit drugs and their metabolites’ have no safe-
levels because of insufficient information on their 
biodegradability and persistence after their disposal to lands or 
receiving waters. Insufficient information, decisions and policy 
thrusts regarding the future practices of safe sewage-sludge 
disposal mean that complete removal of contaminants from 
STWs effluent-waters becomes difficult. 
Existence of uncontrolled discharges of different types of 
compounds from humans and from veterinary treatment into the 
environment via STWs is shown in the anticipated exposure in 
Figures 17 and 18. Drugs for human treatment are primarily 
exposed to the environment from routes Fig 17 (F1 & F2) and 
enter different treatment fate processes at points F3 & F4 and 
terminate at F8 and F9. 
 
 
Figure 17. Anticipated exposure routes of drugs for human 
treatment in the environment [186] 
The effects on terrestrial and aquatic organisms continue 
with drugs from veterinary treatment in Fig. 18 (F10-F13) in 
another complete process of bio-chemical reactions and 
mechanisms with anticipated toxicity impacts on the ecosystems 
not yet understood. 
Studies in the literature have confirmed the enrichment of 
the sewage sludge partitioning of chemicals onto sludge solids 
or suspended in solution is due to their 
hydrophilicity/lipophilicity properties compared to influent 
sewage [187-189]. Understanding of the fate and behaviour of 
pollutants during sewage treatment will show the degradation 
possibility of compounds that are completely or partially 
degraded in aqueous and solid phases, sorbed to sludge solids or 
mineralised. In a study reported by Strachan et al [190], organic 
contaminants are located within the fraction of large organic 
wastes (biomass) which are repository of living and dead micro-
organisms required for degradation processes.  
 
Figure 18. Anticipated exposure routes of drugs for 
veterinary treatment in the environment [186] 
Microbial degradation in the aquatic environment 
Investigations on the levels of removal of organic residues 
from a wastewater plant studies have shown toxicity correlation 
of wastewater effluents on aquatic organisms to determine the 
response levels with degree of contamination [191-193]. 
Biodegradability studies of organic priority pollutants and 
reduction in toxicity of these pollutants in wastewaters treatment 
processes have also been carried out [194-195]. Also evaluated 
were 22 priority pollutants belonging to the class of phthalates, 
pesticides, polycyclic aromatic hydrocarbons and phenols in an 
activated sludge pilot plant [111, 194]. About 80-99% removal 
efficiency was recorded from the parallel and spiked treatments 
of between 50-150 µg L-1 concentrations. The results indicated a 
degradation of phenols, enrichment of PAHs to about 64% from 
the mass balance calculations while pentachlorophenol was 
associated with the solid phases. Table 5 presents percent 
sewage sludge disposal in the last 3 years, and the subsequent 
transport of these residual organic pollutants in the sewage 
which enters the environment and becomes the issue of current 
concern. 
Sewage is a complex association of wastes of human 
excreta containing mixtures of fats, sugars, lignin, protein, 
cellulose, humid materials, amino acids and fatty acids. Wang et 
al [197] studied the partitioning mechanism of the organic 
residues within the biomass and sorption onto the sludge surface 
as a two-stage process. Determination and prioritisation of 
typical sewage sludge can be a complex task because of many 
synthetic organic materials with various residues of diverse 
origins due to 1) interferences of co-contaminants in complex 
matrices, sample extraction and clean ups, sensitive techniques 
needed to determine low concentrations 2) the fate and 
behaviour of sludge-derived residues after disposals requires 
investigation to monitor persistence and environmental impacts 
and 3) bio-transformation arising from degradation of residues 
generates toxic by-products, but unavailability of some 
compounds, sorped onto sewage solids to bacteria for 
degradation can be significant as little is known about the final 
fate of these organics [198-202]. Difficult isolation of sludge 
samples arises also from non-uniformity of extraction 
procedures and variability in obtaining grab samples as a 
representative of all various genotoxins in the sludge matrix 
[203-205]. Different processes or techniques are often adopted 
for specific effluents depending on the origins of the 
contaminants. Generally factors often considered, though 
contaminants can be lost during treatments in a complex variety 
of ways are: 1) sorption/association with sewage solid surfaces 
2) abiotic processes/hydrolysis involving chemical degradation 
3) volatilisation and 4) biodegradation [111].  
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Humans are typically exposed to numerous organic and 
inorganic pollutants, as by-products from treatment of waste 
water from domestic, agricultural and industrial sources which 
constitutes sewage [206]. The presence of intestinal pathogenic 
bacteria and animal parasites in sewage sludge has been 
confirmed from several investigations [207, 208]. However, 
sewage sludge may contain relatively large amounts of heavy 
metals as well as organic pollutants such as phthalates, 
polychlorinated biphenyls (PCBs), alkyphenols, and 
organoclorine pesticides compared to normal environmental 
levels in soil, water, and air [2]. Increasing amounts of sewage 
sludge are used for land filling and agricultural land including 
pastures grazed by ruminants following the ban on ocean 
dumping of sludge [209]. The potential health risk imposed due 
to the presence of organic and inorganic compounds found in 
sewage sludge is of concern in humans [210, 211] if they are 
delivered at high enough doses to cause effects through the 
consumption of products derived from animals grazing on 
contaminated pastures [212]. Adverse effects which have been 
reported in humans include perturbation of male reproductive 
tract, certain male and female cancers, declined fertility, thyroid 
dysfunction and ill impacts on the central nervous system, 
gastroenteritis, damage to liver, kidneys and blood, hepatitis, 
occupational asthma, infection of skin or eyes and inflammation 
of the lung following sewage sludge exposure.  Different groups 
of environmental chemicals with a variety of mechanisms and 
disrupting activities have been identified and discussed [213-
218]. 
In the literature, degradation studies of pharmaceuticals 
have identified degradates of anti-inflammatory, analgesics and 
blood-lipid regulators. In batch studies of acetylsalicylic acid 
with suspended activated sludge, the decrease of about 70-99% 
in concentration after 6, 24 and 72 h was observed but no 
metabolites were detected using GCMS [89]. The degradation 
studies of anti-inflammatory and blood-lipid regulators such as 
bezafibrate, diclofenac, naproxen and ketoprofen in activated 
sludge were carried out, but only ketopofen biotransformed into 
[3-(hydroxyl-carboxy-methyl) hydratropic acid and [3-(keto-
carboxyl- methyl) hydratropic acid [89]. Biodegradation of 
trimethoprim showed resistance to degradation in a reactor filled 
with activated sludge, but its degradation in a nitrification 
process was completed in 3 days. In a similar study, Ternes et al 
[89] investigated degradability of estrogens in aerobic batch 
reactors at two different concentrations using GCMS. The 17β-
estradiol was oxidised to estrone without any detectable 
degradates. Also, 16α-hydoxy-estrone was similarly degraded 
without degradation products. In a subsequent work, the 
biodegradation studies of trimethoprim, anti-tumorals cisplatin, 
cyclophosphamide, cytarabine, X-ray contrast agents, iopromide 
and diatrizoate has been carried out but not all the details of 
metabolites identification were reported [89]. 
Concerning the degradability of illicit drugs, apart from 
sample degradation, biodegradation is a natural process that has 
been reported by the stability experiment conducted by Georghe 
et al [219] and which observed that the concentration of cocaine 
and ecgonine methylester changed in surface water by 40 and 
95% after 5 and 24 h test period respectively. However, 
benzoylecgonine   level was constant or increased in the study. 
Photodegradation is another abiotic process involving complex 
reactions and pathways that could affect the aquatic fate of 
compounds, particularly when degradates are resistance to 
hydrolytic processes [220].  Four relatively new metabolites of 
cocaine: ecgonidine, norecgonidine methylester, p- hydroxyl-
benzoylecgonine, and m- hydroxyl-benzoylecgonine [221], and 
two conjugates of metamphetamines: p-hydroxy-
metamphetamine (p-OHMA-sulfate), (p-OHMA-Sul) and (p-
OHMA) (p-OHMA-glucuronide) [220] have been identified in 
human urine. 
The identification of this phase-II degradates and other 
metabolites in urine indicate likelihood of their presence in 
wastewater samples, unless they are further degraded in the 
sewage treatment works.   
In a study, Pizzolato et al [150] observed the 40-80% 
degradation of cocaine and its metabolites in river waters under 
sunlight and pseudo-sunlight after 11 days of exposures as 
compared to HPLC grade water. Degradation was about 80% 
faster in river water as cocaine degraded to benzoylecgonine 
confirming the effects of both biodegradation and 
photodegradation.  
Identification of microbial metabolites of ibuprofen has 
been found to be identical with the compound human 
metabolites [222-223]. During wastewater treatment, apart from 
the sorption behaviour of potential organic contaminants to the 
sludge solids, the removal of organic residues and associated 
metabolites are through microbial degradation as earlier reported  
as part of the removal mechanism of some pharmaceuticals and 
endocrine disrupting compounds (EDCs) in the sludge [80-83]. 
Hydrolysis (abiotic process) is the most important mechanism in 
the chemical degradation pathways through which compounds 
are removed [234]. The enrichment of the sewage sludge 
partitioning of chemicals onto sludge solids or suspended in 
solution is due to their hydrophilicity/lipophilicity properties 
compared to influent sewage [187-189]. 
Table 6 summarises the drugs and their metabolites identified 
from both human biological fluids and aquatic environments.  
Appreciation of the degradation possibility of compounds 
whether they be completely or partially degraded in aqueous and 
solid phases, sorbed to sludge solids or mineralised is an 
important step in understanding the fate and behaviour of 
pollutants during sewage treatment. Within the large organic 
wastes in sewage is biomass of living and dead micro-organisms 
required for degradation processes within which some fractions 
of organic contaminants could be found. Sequential biological 
processes in alternating oxidative and reductive conditions for 
recalcitrant organic compounds plays a major role in removal 
mechanism [111, 190, 252]. 
In the degradation studies of alkylphenol polyethoxylate 
(APEO) surfactants, the recalcitrant and estrogenically active 
alkylphenols (APs) were produced from commercial NPEO 
using synthetic activated sludge in batch tests. The levels and 
distribution of the short chain compounds after NPEOs 
degradation confirmed in many ways these routes by which 
pollutants are discharged to the aquatic environment due to 
incomplete removal from treatment processes [253]. In activated 
sludge, viable and diverse bacterial population is maintained 
when the biological sludge is re-cycled from settling tank back 
to the aeration tank to produce high quality effluent, reduced 
biomass, maximised conversion of substrate and less production 
of waste sludge The oxidation of organic matter in an biological 
aerobic process generates carbon dioxide and water with the 
new but reduced biomass and dissolved residual organic matter 
in the effluent [224]. In related studies, Richardson and Bowron 
[93] assessed the biodegradability of some specific chemicals as 
presented in Table 7, but yet to be investigated are the 
degradation processes as well as the extent of transformations in 
producing different chemical metabolites [111]. Pathways of 
microbial degradation of selected acidic pharmaceuticals and 
their occurrence in municipal wastewater treated by a membrane 
bioreactor have been reported [254]. To further understand the 
behaviour of compounds in sewage plants, studies of 
metabolites from the biodegradation of pharmaceutical residual 
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of ibuprofen in biofilm reactor also confirmed the effects of 
biodegradations [222] 
Elimination of selected acidic pharmaceuticals from 
municipal wastewater using activated sludge systems and 
membrane bioreactors [255], modelling versus measurement 
experiment of effluent from hospitals and private households to 
the total loads of diclofenac and carbamazepine in municipal 
sewage effluent [256] and identification of microbial 
degradation of trimethoprim in nitrifying activated sludge batch 
studies have been reported in the literature.  
Stability of drugs and metabolites 
The stability of drugs and their metabolites in the aqueous 
environment depends on some conditions of temperature and pH 
to minimise degradation of analytes. Studies recommended the 
acidification of samples to pH 2 and - 20o C for storage in a 
stability study of cocaine and its metabolites (e.g. 
benzoylecgonine and ecgoninemethylester) where a pond free of 
drugs was spiked with different concentration of cocaine and 
benzoylecgonine at modified pH values of 2 and 6 and 
temperatures (-20oC, +4oC and +20oC) for 5day stability tests. 
The 22% degradation of cocaine after 3 days and 35% after 5 
days at pH 6 and +4oC were observed. Also, ca.75% degradation 
was observed at +20oC at pH > 6 for 1 day [158]. Using 
different preservation conditions, some decreases in the 
concentration of cocaine (36%), cocaethylene (13%), nor-
cocaethylene (15%) and M3G (96%) and changes led to  
corresponding changes in the levels of  metabolites (BZE, nor-
BZE and MOR) respectively with the optimal conditions for 
storage similar to that observed for Cocaine, BZE and EME 
[219]. Similar works have also shown preserved samples at -
20oC with addition of HCl (pH 2) stopping bacterial action. 
Cocaine stability in wastewater at 4o C for 48 hours was 
investigated but no changes were observed. Storage experiments 
with methanolic extracts for 7 days at different temperatures 
observed degradation of up to 15% with extracts stored at +4oC 
but no changes with those stored at -20oC [244, 159, 257]. 
Stability of other drugs of abuse like heroin, amphetamines-like 
substances and lysergic acid and their metabolites were not 
found in the literature. 
Analytical Methodologies 
In recent years, important advances in the development of 
chromatographic and mass spectrometric methods have been 
made, particularly in the detection and quantitative measurement 
of illicit drugs and their metabolites in various biological and 
aquatic matrices. The techniques based on liquid 
chromatography- mass spectrometry (LC-MS) or liquid 
chromatography tandem mass spectrometry (LC-MS2) and gas 
chromatography-mass spectrometry (GC-MS) or gas 
chromatography tandem mass spectrometry (GC-MS2) are very 
popular primarily because of their ability to detect and measure 
chemical substances at very low concentration. In addition to 
analytical methods for tracing pharmaceuticals residues in water 
and wastewaters that have been extensively used [93, 97-101], 
other analytical procedures for quick screening of drugs residue 
in aqueous environments including several inexpensive 
immunochemical approaches, as an alternative method to the 
chromatographic techniques for the efficient analysis of 
pharmaceuticals have also been published [96]. 
Chromatographic techniques  
Table 8 shows the survey of
 
chromatographic techniques 
from peer-reviewed literature in the determination of illicit 
drugs and human metabolites in waters. The review covers the 
extraction volumes, mobile phases, detectors (interfaces) and 
acquisition modes used by different scientists to provide 
sensitivity and selectivity. Also included are limits of 
quantifications depending on matrices for quantification and 
confirmation of drugs. The HPLC separation procedures rely on 
the principles of reversed-phase columns with different solvent 
gradients depending on applications [247-249]. Recently, 
variations over conventional LC-MS method have appeared in 
the literature eg. Ultra-performance liquid chromatography 
(UPLC-ESI-MS/MS), the ultra-fast UPLC-MS2 is unique for its 
short columns packed with small particles sizes and stability at 
different pH range [135, 266 -268]. With the development of 
this relatively new technology, a shorter analysis time as well as 
gain in separation efficiency, resolution and sensitivity has been 
reported. To minimised the effects of ion suppression on the 
analytical signal, a relatively new HILIC; Hydrophilic 
interaction chromatography technique was also carried out in 
some experiments. Analytes were better retained on HILIC 
column, unaffected by ion suppression and a reduction in 
analytical signal was minimised [158, 219].  
The use of MS/MS with triple quadrupole (QqQ) analyzers 
with electrospray ionization (ESI+) were mostly used in selected 
reaction monitoring mode (SRM) to minimize the matrix 
interferences. The choices of ionization in ESI positive-ion 
mode were to have achieved ionizations and simultaneous 
determinations of analytes.  
The HPLC-MS methods are also used in the analysis of 
illicit substances in the literature [208,214]. Both HPLC and 
GC-MS have been applied in the determination of 
pharmaceuticals in different matrices of biological fluids [262-
265] especially urine [266-269], oral fluid [225, 226], and blood 
[227] samples. The advantage of HPLC-MS in the determination 
of the main illicit drug classes including cocaine, amphetamines, 
opiates and synthetic opiods, cannabinoids and their metabolites 
is due to its no hydrolysis, no derivatization, one- step extraction 
and with the introduction of atmospheric pressure ionisation 
(API) interfaces, the technique has been popular [269]. HPLC is 
a good and popular technique for highly polar, high molecular 
weight and thermolabile compounds.  Its reproducibility, 
sensitivity and overall lower costs have therefore made it a 
convenient method. The use of GCMS is very rapid, faster and 
highly specific with in-built NIST library softwares for 
compound identification and elimination of matrix effects. 
Principle of the choice of method (SPE-GC-MS):  The trace 
analysis in wastewater can be captured as simple liquid 
chromatographic  process where the SPE sorbent acts as the 
stationary phase and water constitutes the mobile phase during 
the extraction. During the percolation step, analytes that are 
trapped and cannot elute constitute the sample matrix. The 
enrichment of analytes from a large volume of aqueous sample 
on sorbent depends on how strongly the analytes are retained 
while allowing low retention during elution with organic 
solvents. 
The method of coupling of SPE to GC-MS can be directly 
integrated as an online analytical system or off-line where 
subsequent chromatographic analysis is completely separated 
from the sample treatment. As long as the compounds are 
sufficiently thermally stable and volatile enough, gas 
chromatography (GC) allows a broad variety of samples to be 
analysed. As for all other chromatographic techniques, a mobile 
(carrier gas e.g. helium, argon, nitrogen, etc. ) and a stationary 
phase (packed column or solid support coated with the liquid 
stationary phase of high boiling polymer e.g capillary columns 
of a small-diameter tube like 0.25 mm film in a 0.32 mm tube) 
are required . Different compounds are separated due to the 
interaction of the compound with the stationary phase (“like-
dissolves-like”-rule). The stronger the interaction is,  the longer 
the compound remains attached to the stationary phase, and the 
more time it takes to go through the column (longer retention 
time). GC-MS is a good combination of coupled analytical 
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systems as GC separates the compounds then MS identifies 
them based on their fragmentation pattern. 
Solid Phase Extraction (pre-concentration) 
Table 9 shows the multi-step extraction procedures of 
different protocols which have been reported in the peer-
reviewed literature, to eliminate the influence of matrices 
[124,159]. Apart from matrix effect, improved recovery, 
stability under pH and ability of delivering clean extracts have 
resulted into various tests of several SPE adsorbent to determine 
suitable parameters relevant to a particular application need. 
Several SPE methods and adsorbents have been developed and 
used in conjunction with LC-MS2 or GC-MS2 in the 
determination of illicit drugs and their metabolites in aquatic 
media at very low concentrations (ng L-1 levels). Recently, Oasis 
MCX® (500mg/6mL) adsorbent, a polymeric sorbent with 
mixed–reversed/strong cation-exchange sulfonic acid group 
located on the surface of a (divinylbenzene-co-N-vinyl 
pyrrolidone) has been used [259, 270] to extract drug analytes 
from aqueous samples. After the samples were adjusted to pH 2 
with 37% HCl or 0.01NHCl, the cartridge was pre-conditioned 
with 6ml of MeOH, 3mL of milli-Q water and 3mL water at pH 
2. Samples were loaded into the cartridges at flow rate between 
5-20mL min-1, vacuum-dried for 5min and eluted with 6mL of 
MeOH and 6ml of 5% NH3 in MeOH. The cartridges were 
found to be stable perhaps because of its two phases that were 
assumed could retain all compounds investigated. In related 
development Wylie et al [225] and Miltona et al [266] have 
used Bond Elut Certify®, a lipophilic and strongly cationic- 
adsorbent with similar conditioning and washing steps as used 
with Oasis MCX® adsorbent, the only difference was 2 x 4 mL 
of 80:20 DCM/isopropanol mixtures with 2% NH3 in elution 
step.  Traditional SPE materials such as the modified silica’s e.g. 
C8, (octyl), C18 (octadecyl) or CN (cyanopropyl) materials have 
low pH range, poor selectivity and residual silanol group which 
often leads to low recoveries in aqueous sample [82,90].   
Bones et al [94] investigated the use of three sorbents: 
Phenomenex Strata- X™, Strata- XC™ and Strata- XCW™, all 
in 200mg sorbent mass pre-packed in to 6mL cartridges, but 
Strata- XC™ provided the highest analyte recovery. In other 
experiments, the Oasis HLB® (500mg/6 mL) adsorbent [278], 
MCX® (500mg/6mL) [159], Isolute ENV+® (500mg/6 mL) and 
Isolute PH® (1000mg/6 mL) adsorbents  [245], and Bond Elut 
Certify® adsorbent [225] were compared with other adsorbents 
by Gheorge et al [219] in the extraction of cocaine and its 
metabolites in waste and surface water and the authors 
recommended the use of Oasis HLB® (500mg/6 mL, protocol 1) 
as most suitable adsorbent for organic compounds because of its 
lower solvent  usage, time, stability to pH range and over 75% 
recovery for most analytes in aquatic medium.  
 
Results and conclusions of survey of drugs in wastewaters 
Generally, the illicit drug detection has been limited to the 
continuous screening of individual’s biological fluids (urine, 
blood, oral-fluids and sweat), population survey with crime, 
drug production data, drug seizures and medical records 
[273,274]. The official estimates of the community consumption 
of illicit drugs from these exercises can be very unreliable 
because of the hidden nature and network of manufacture, 
importation, supply and usage without authorisation.  Globally, 
United Nation Office of Drugs and Crime, (UNODC) estimates 
that between 149 and 272 million people, or, 3.3% to 6.1% of 
the population aged 15-64 used illicit substances at least once in 
the previous year [275]. Drugs are used in many ways and in 
many combinations by prescription for medical purposes, some 
illicit drug users often utilise therapeutic pharmaceuticals to 
supplement their illicit drug use by diverting common 
pharmaceuticals for illicit   personal use and this illegal practice 
have affected societies in a myriad of ways. However, with the 
continuing pattern of escalation in use of illicit drugs and the 
discharge of their bioactive metabolites to sewage systems, and 
the present mode of sewage disposal (e.g. to grassland, landfills, 
incineration, horticulture, land reclamation) as complex 
mixtures so the processes involved in drugs removal at various 
STWs are not fully understood.  Table 4 therefore summarises 
and compares the levels and distribution of the drugs from 
different STWs as reported in the literature in the last ten years. 
Also in Table 4, it was observed that the relative concentrations 
of drugs influents were higher compare to the effluents 
indicating the degree of removals. For example in 5 STWs in 
Spain, cocaine and benzoylecgonine in the influents were
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and 2307 ng L-1 compare to only effluent cocaine concentrations 
of 47 ng L-1.  The relative concentration of benzoylecgonine for 
example is about 10 times higher than the parent drug. 
The removal of organic compounds is often incomplete in 
most municipal WWTPs; the sewage-sludge and effluent waters 
are therefore the primarily routes at which these chemicals enter 
the environment. Apart from the biodegradation, chemical 
degradation and sorption processes in typical WWTP of which 
details are not well understood because of the complex mixtures 
present during the wastewater treatment. The physicochemical 
properties of the contaminants ultimately determines their extent 
of persistence, toxicity and potential environmental effects after 
the sewage-sludge disposal to agricultural lands or effluents 
waters disposed of to seas. The existing priority substance 
classifications by the European Commission and U.S. 
Environmental Protection Agency notwithstanding [185]; the 
emerging priority contaminants groups like ‘illicit drugs and 
their metabolites’ have no safe-levels because of insufficient 
information on their biodegradability and persistence after their 
disposal to lands or receiving waters. As a result of insufficient 
information, decisions and policy thrusts regarding the future 
practices of safe sewage-sludge.  
The illicit drugs and their metabolites are mainly from 
faeces and urination, the pattern of lavatory use fluctuates 
between individuals, certain periods of work and the population 
of residents in a particular environment, the load pattern of illicit 
substances would likely fluctuate in similar way [144]. Since 
many active researches have been on detection of illicit drugs 
and related products, studies on their fate and behaviour are 
therefore most warranted. 
We have therefore critically reviewed the current development 
on the occurrence, metabolism, treatment processes, 
measurement before and after discharges from STWs to the 
environment with the current analytical methodologies that meet 
particular application needs such as fate of drugs monitoring. 
With the developments on different aspects of drug’s 
transformations in the environment recently published in the 
chemical literature which includes occurrence and fate, 
treatability by conventional and non-conventional processes, and 
several miscellaneous others [276-293]. The pharmaceutical and 
illicit markets will continue to grow to provide numerous 
commercial and therapeutic purposes. Today, large numbers of 
new drugs are introduced into the market and the number of 
patents granted keeps increasing accordingly. As these products 
reach the market with already large number of pharmaceutical 
companies involve in their development continue to grow.  
Information in the literature on the distribution levels, laboratory 
studies of fate and behaviour of some classes of illicit and 
pharmaceuticals drugs and their environmental assessment are 
rapidly changing.  It is not very clear if current chemical 
pollution approaches in terms of effective monitoring and 
control of chemical discharges into the aquatic environment 
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would achieve desired effect and environmental scientist will 
have to be ready for new challenges ahead. 
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